Skip to main content

SRPT Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Sarepta Therapeutics Inc. News

Why Wall Street Doubts This Biotech Penny Stock Will Be Delisted

The share price dipped below $1 -- into penny stock territory -- but analysts are optimistic they'll recover.

Barclays Lists Halliburton, Dick's, Ally as 2022 Earnings Winners

Barclays made a list of 35 stocks with overweight ratings that it expects to benefit from strong earnings next year.

Sarepta Higher After Progress With Muscular Dystrophy Drug Trial

Sarepta's trial supports its drug's 'potentially differentiated profile' to treat Duchenne muscular dystrophy, the company said. The stock is higher.

Boeing, Micron, Pfizer, Sarepta - Friday's Premarket Movers

Stocks moving in premarket trading Friday include Boeing, Micron, Pfizer, Sarepta and Moderna.

Sarepta Sinks on Disappointing Gene-Therapy Study Results

Sarepta shares lose half their value after a gene-therapy study seen as a shoo-in treatment for Duchenne muscular dystrophy produces disappointing results.

Breaking News

Disney Mobile Game Opens Up a New Universe

Familiar Disney characters populate an alternate reality in new interactive game.

Birth Control Stocks May Benefit From the Reversal of Roe v. Wade

The historic Supreme Court decision may force women to make different choices.

Something Strange is Happening With Home Prices

As mortgage rates hit fresh highs, there's something unusual going on with the real estate market.

Roe Decision Forces Disney, Netflix to Take a Political Stand

Disney, JP Morgan Chase, and outgoing Meta COO Sheryl Sandberg are just a few speaking out against the ruling.